体外研究
Isobavachalcone (6.0-48.0 μM; 72 hours; OVCAR-8, PC3, A549, MCF-7, L-02 and HUVEC cells) treatment inhibits the proliferation of human cancer cells. Isobavachalcone inhibits PC3, A549, MCF-7, L-02 and HUVEC cells growth with IC50 values of 15.06 μM, 32.2 μM, 28.29 μM, 31.61 μM and 31.3 μM, respectively.
Isobavachalcone (0-18 μM; 6 hours; OVCAR-8 and PC3 cells) treatment results in a concentration-and time-dependent down-regulation of the Ser-473 phosphorylation of Akt and GSK3b phosphorylation.
Isobavachalcone (0-18 μM; 72 hours; OVCAR-8 and PC3 cells) treatment causes apoptosis via caspase- and ROS-involved mitochondrial pathway.
Cell Proliferation Assay
Cell Line:
OVCAR-8, PC3, A549, MCF-7, L-02 and HUVEC cells
Concentration:
6.0-48.0 μM
Incubation Time:
72 hours
Result:
Inhibited the proliferation of human cancer cells.
Western Blot Analysis
Cell Line:
OVCAR-8 or PC3 cells
Concentration:
0 μM, 6 μM, 12 μM, and 18 μM
Incubation Time:
6 hours
Result:
A concentration-and time-dependent down-regulation of the Ser-473 phosphorylation of Akt. GSK3b phosphorylation was also inhibited in a concentration- and time-dependent manner.
Apoptosis Analysis
Cell Line:
OVCAR-8 cells and PC3 cells
Concentration:
0 μM, 6 μM, 12 μM, and 18 μM
Incubation Time:
72 hours
Result:
Led to dose dependent increase of apoptosis.